Accepted8 March 1989 Analysis has taken two forms. Firstly, cohort analysis describes the mortality experience of successive generations. By comparison of the age specific mortality rates for bronchitis, asthma, and emphysema in groups born at around the same time, it is possible to detect trends and, further, identify influences to which all or some members of the group have been exposed that may explain that mortality.3 Over the period investigated there have been eight revisions of the International Classification of Diseases and the ICD codes used under each revision are set out in the table.
The complexity of the changes in classification for bronchitis, asthma, and emphysema over the years is such that the only way to achieve continuity is to combine all three diseases. Included since 1979 are deaths from chronic airways obstruction (ICD/9 code 496), which were omitted in a previous cohort analysis. 4 The second part of the analysis presents recent trends in mortality for bronchitis, emphysema, and chronic airways obstruction. Age specific mortality rates have been obtained for both sexes for ages 45 was decided for clarity to concentrate on the years since the introduction of the ninth revision, 1979-86. The ICD codes used are 490-492 and 496. All data were obtained from published mortality statistics.5
Results
The results ofthe birth cohort analysis are presented in figures 1 and 2. As expected, the mortality rates for males are far higher than those for females, particularly in the older age groups. At ages 65-84 years in all the cohorts studied rates for men are around five 
Discussion
The difficulties inherent in the interpretation of cause specific mortality trends over time are well known. Greater knowledge of the pathology of disease, improved diagnostic facilities, and changing terminology and coding systems may all distort real trends in incidence and mortality.' It is, therefore, important to be aware of factors that may have an impact on the validity of trends to ensure that detected changes are not artefactual.
International variations in certification and coding practices are well documented." Reid and Rose found that, in an international sample of doctors asked to "certify" causes of death in a series of case histories according to their normal practice, British doctors were more likely to classify a death as due to chronic bronchitis than their Norwegian or American counter, parts. Clinicians in the United States have always regarded bronchitis as a less severe condition than their British colleagues, preferring instead to diagnose emphysema or bronchiectasis.' This international confusion over terminology has been clarified to some extent in recent years, but is by no means completely resolved." 12 Fletcher points out that where the diagnosis ofdisease is defined according to loss of function there will inevitably be disagreement until consensus can be reached on the limits of normality. This consensus has still apparently not been reached, so confusion over diagnosis and hence certification persists. These considerations of the impact of certification practice on international differences are relevant to within country variation over time. The most obvious reason for changing diagnostic and certification practice over time is current thinking among clinicians, both throughout the period of medical education and at the time of practising. The rapidly changing distribution ofcause ofdeath within the category chronic obstructive airways disease suggests a current fashion for chronic airways obstruction. The increasing number of deaths taking place in hospital also has an impact. Kelson and Heller found a difference in certification practice between hospital doctors and general practitioners in England and Wales.'3 If fewer deaths are being certified by general practitioners this could influence the trends in published mortality rates.
The period under review, as already mentioned, encompasses eight revisions of the International Classification of Diseases, and inevitably the categories in each successive revision do not wholly correspond to those of the previous one. Comparability therefore is only approximate. This problem is further compounded by the exclusion, until the ninth revision, of chronic airways obstruction within the categories of bronchitis, asthma, and emphysema. In the eighth revision chronic airways obstruction was classified under "Other diseases ofthe respiratory system" (ICD 519). Once it became apparent that this was a growing category, chronic airways obstruction was allocated its own four digit code, 519-8, but separate data are available only for 1978. Before then the data on which 532 the analysis is based are not comprehensive, though the proportion of deaths allocated to chronic airways obstruction before the late 1970s is likely to have been small. The second part of our analysis-the monitoring of recent trends since the introduction of ICD 9-does not suffer from these limitations in the data. Yet even within this time period coding changes have been made that have had an important effect. After an investigation into the apparent increase in deaths from pneumonia, it was decided to alter the coding rules for certain conditions, including bronchopneumonia' ,s In the wake of these observations, it is tempting to conclude that the current vogue for chronic airways obstruction and the complex changes in the coding system have contributed more to the apparent reversal of a declining mortality trend than any actual change. Any artefactual explanation, however, would operate with equal force for both sexes, and the mortality of men and women would be similar." The fact that this is not the case suggests that the upward trend among older women, at least in part, is real. Of all the risk factors identified and investigated for chronic bronchitis, by far the most important is smoking. '7 18 It is therefore plausible that the difference in mortality patterns between men and women reflects their differing smoking habits, the decline in smoking being far slower among women. Recent 
